CME-Certified program jointly-sponsored by Cleveland Clinic Foundation Center for Continuing Education and Society for Immunotherapy of Cancer. This program was also in collaboration with Case Comprehensive Cancer Center.
Presentations from this program are available through the program schedule tab. |
|
James H. Finke, PhD - Cleveland Clinic
Joseph Baar, MD, PhD - Seidman Cancer Center
Brian I. Rini, MD - Cleveland Clinic Taussig Cancer Center
F. Stephen Hodi, Jr., MD - Dana-Farber Cancer Institute
Howard L. Kaufman, MD, FACS - Rush University Medical Center
Specifically designed for the entire unit of care involved in treating cancer, this program provided an understanding of immunology principles related to the clinical application of immunotherapy agents, as well as basic and clinical immunology research and immunotherapy of malignancy.
Through several lectures by leading cancer immunologists with an expertise in the clinical application of these treatment options, this program summarized central themes in research advances and approvals to 1) facilitate understanding of more sophisticated principles of tumor immunology and immunotherapy and 2) promote appropriate clinical application of cancer immunotherapies, how they work, their side effects and the efficacy to improve patient outcomes.
Attendees also took advantage of the opportunity for professional networking that promoted collaboration and scientific exchange with experts and clinical oncologists from the surrounding community.
The target audience for this program included practicing clinical oncologists, those involved in patient care, early career individuals, allied health professionals, and patient advocates who wish to learn increasingly sophisticated principles of tumor immunology and immunotherapy, as well as the role of inflammation in cancer development.
Upon completion of this program, the participant should have been able to:
Jointly sponsored by Cleveland Clinic Foundation Center for Continuing Education and the Society for Immunotherapy of Cancer
|
In collaboration with Case Comprehensive Cancer Center
The Cleveland Clinic Foundation Center for Continuing Education and the Society for Immunotherapy of Cancer acknowledged educational grants for partial support of the Advances in Cancer Immunotherapy series from:
Americans with Disabilities Act